n(6)-carboxymethyllysine has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Pang, M; Shao, C; Sun, Z; Wang, Z; Zhang, L | 1 |
| Franke, S; Hein, G; Lehmann, G; Stein, G; Wiegand, R | 1 |
2 other study(ies) available for n(6)-carboxymethyllysine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Nε-Carboxymethyl-Lysine Mediates Vascular Calcification in Diabetes Caused by Impaired Osteoclastic Resorption Activity Through NFATc1-GNPTAB.
Topics: Bone Resorption; Cell Differentiation; Diabetes Mellitus; Humans; NFATC Transcription Factors; Osteoclasts; Plaque, Atherosclerotic; Transcription Factors; Transferases (Other Substituted Phosphate Groups); Vascular Calcification | 2023 |
Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.
Topics: Adult; Aged; Analysis of Variance; Arginine; Bone Resorption; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Osteoporosis | 2003 |